Stock data
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR) reported net income of -US$12.16M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$12.89M | -US$12.16M | — |
| 2024 | — | — | -US$11.12M | -US$10.73M | — |
| 2023 | — | — | -US$14.58M | -US$8.24M | — |
| 2022 | — | — | -US$19.79M | -US$29.93M | — |
| 2021 | US$0.00M | — | -US$39.48M | -US$41.88M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.83M | — |
| 2026-03-31 | — | -US$3.18M | — |
| 2025-12-31 | — | -US$1.70M | — |
| 2025-09-30 | — | -US$2.00M | — |
| 2025-06-30 | — | -US$4.02M | — |
| 2025-03-31 | — | -US$4.45M | — |
| 2024-12-31 | — | -US$3.84M | — |
| 2024-09-30 | — | -US$2.31M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.